Retrospective Review on the Use of Topical Cyclosporin A 0.05% for Paediatric Allergic Conjunctivitis in Hong Kong Chinese

Retrospective Review on the Use of Topical Cyclosporin A 0.05% for Paediatric Allergic Conjunctivitis in Hong Kong Chinese

Purpose. To evaluate the efficacy of using topical cyclosporin A 0.05% (Restasis) for the treatment of paediatric allergic conjunctivitis. Methods. This retrospective study included consecutive cases of paediatric allergic conjunctivitis treated with Restasis between 2010 and 2013. Subjects with fol...

Full description

Bibliographic Details
Main Authors:	Macy M. S. Wu, Gordon S. K. Yau, Jacky W. Y. Lee, Amy L. Wong, Victor T. Y. Tam, Can Y. F. Yuen
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	The Scientific World Journal
Online Access:	http://dx.doi.org/10.1155/2014/396987

Similar Items

Efficacy of topical cyclosporine 0.05% eye drops in the treatment of dry eyes
by: Haitham Y Al-Nashar
Published: (2015-01-01)

Topical application of 0.05% cyclosporine A as an adjunct to LASIK
by: E. V. Kudryashova, et al.
Published: (2015-12-01)

The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery
by: Turan-Vural E, et al.
Published: (2011-06-01)

Efficacy of topical carboxymethyl cellulose 0.5% and cyclosporine A 0.05% in dry eye syndrome
by: Sangeeta Shah, et al.
Published: (2017-01-01)

Topical cyclosporine A 0.05% before and after surgery to prevent pterygium recurrence
by: Roberta Lilian Fernandes de Sousa Meneghim, et al.

Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
by: Mizoguchi T, et al.
Published: (2017-09-01)

Effect of topical 0.05% cyclosporine A on corneal endothelium in patients with dry eye disease
by: María Castro-Rebollo, et al.
Published: (2013-08-01)

Effect of 0.05% topical cyclosporine for the treatment of symptomatic subepithelial infiltrates due to adenoviral keratoconjunctivitis
by: Ilkay Kilic Muftuoglu, et al.
Published: (2016-04-01)

FEATURES OF 0.05% CYCLOSPORINE (RESTASIS) APPLICATION IN TREATMENT OF RECURRENT INFILTRATIVE ADENOVIRAL KERATITIS
by: D. Y. Maychuk, et al.
Published: (2015-10-01)

Effect of topical 0.05% cyclosporine A on the tear protein lacritin in a rat model of dry eye
by: Fen-Dui Zhang, et al.
Published: (2019-02-01)

Efficacy, Safety and Steroid-sparing Effect of Topical Cyclosporine A 0.05% for Vernal Keratoconjunctivitis in Indian Children
by: Arkendu Chatterjee, et al.
Published: (2019-10-01)

A Comparative Study of Efficacy and Safety of Topical Loteprednol Etabonate 0.5% and Cyclosporin A 0.05% for the Treatment of Vernal Keratoconjunctivitis
by: Sharika Ganjoo, et al.
Published: (2020-12-01)

Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease
by: Priyanka V Gandhi, et al.
Published: (2021-01-01)

Comparison of Efficacy of Two Different Topical 0.05% Cyclosporine A Formulations in the Treatment of Adenoviral Keratoconjunctivitis-Related Subepithelial Infiltrates
by: Betül N. Bayraktutar, et al.
Published: (2016-03-01)

Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis
by: Rahul Bhargava, et al.
Published: (2019-01-01)

Treatment of ligneous conjunctivitis with amniotic membrane transplantation and topical cyclosporine
by: Ozlem Yalcin Tok, et al.
Published: (2012-01-01)

Clinical efficacy of combined topical 0.05% cyclosporine A and 0.1% sodium hyaluronate in the dry eyes with meibomian gland dysfunction
by: Ho-Yun Kim, et al.
Published: (2018-04-01)

Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies
by: Arthur B Epstein, et al.
Published: (2009-04-01)

Exposição de fibroblastos da cápsula de Tenon de pterígios à ciclosporina 0,05% Exposure of Tenon's capsule fibroblasts of pterygium to cyclosporin 0.05%
by: Laura Almeida Hercules, et al.
Published: (2006-12-01)

Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis
by: Okumus Seydi, et al.
Published: (2012-08-01)

Effectiveness and Optical Quality of Topical 3.0% Diquafosol versus 0.05% Cyclosporine A in Dry Eye Patients following Cataract Surgery
by: Jang Hoon Lee, et al.
Published: (2016-01-01)

Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model
by: Awara A, et al.
Published: (2020-02-01)

Uso de ciclosporina 0,05% tópica no tratamento do olho seco de pacientes portadores do vírus HIV Topical cyclosporine 0.05% for the treatment of dry eye disease in patients infected with the human immunodeficiency virus
by: Rodrigo de Pinho Paes Barreto, et al.
Published: (2009-04-01)

Eficácia da ciclosporina 0,05% na prevenção da perda endotelial no transplante de córnea Efficacy of cyclosporine 0.05% for preventing endothelial loss in corneal transplant
by: Fernando Moro, et al.
Published: (2007-10-01)

The clinical impact of chromosomal microarray on paediatric care in Hong Kong.
by: Victoria Q Tao, et al.
Published: (2014-01-01)

An Experience of Using Cyclosporin 0.05 % (Restasis) in Conjunctival Lymphangiectosia Treatment of Patients With Dry Eye Syndrome
by: S. A. Volik, et al.
Published: (2018-10-01)

Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye
by: Deveney T, et al.
Published: (2018-03-01)

Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
by: Elisa Molinelli, et al.
Published: (2020-04-01)

The Early Efficacy of Topical Levocabastine in Patients with Allergic Conjunctivitis
by: Hiroshi Fujishima, et al.
Published: (2006-01-01)

Aetiology of allergic rhinitis in Hong Kong
by: Christopher W.K. Lam, et al.
Published: (1998-01-01)

Pharmacodynamic and Dermatopharmacokinetic Bioequivalence Studies of Topical 0.05% Clobetasol 17-Propionate
by: YiFang Tsai, et al.
Published: (2001)

Topical olopatadine hydrochloride versus ketotifen fumarate for allergic conjunctivitis
by: Dharmistha Patel, et al.
Published: (2018-01-01)

PERSIST: Physician&#39;s Evaluation of Restasis&reg; Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review
by: Mah F, et al.
Published: (2012-11-01)

Topical Treatment of Truncal Acne with Tretinoin Lotion 0.05% and Azelaic Acid Foam
by: Sharleen St. Surin-Lord, et al.
Published: (2020-01-01)

Allergic Conjunctivitis
by: Muhammed Vally, et al.
Published: (2017-11-01)

Comparative assessment of topical steroids, topical tretenoin (0.05%) and dithranol paste in alopecia areata
by: Das Sudip, et al.
Published: (2010-01-01)

Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial
by: Chang Hyun Park, et al.
Published: (2019-06-01)

Topics in Hong Kong Cantonese syntax
by: XU, JIA-HUI, et al.
Published: (1988)

Efficacy of 0.05% cyclosporine A on the lipid layer and meibomian glands after cataract surgery: A randomized, double-masked study.
by: Min Seung Kang, et al.
Published: (2021-01-01)

IMMUNOPATHOLOGY OF ALLERGIC CONJUNCTIVITIS
by: DeGaulle I. Chigbu, et al.
Published: (2020-10-01)